Skip to Main Content
CKG
Home
Home
Home
TKG
Author details
Breadcrumb
Author Details
Full Name
Alan R Fersht
Affiliation
Medical Research Council Laboratory of Molecular Biology
ORCID
Career Start Year
1967
Papers
551
H Index
127
Expertise
CM4AI Collaborator
Andrej Sali (CM4AI)
PMID
Paper Title
Journal Title
Published Year
34087198
AlphaFold - A Personal Perspective on the Impact of Machine Learning.
J Mol Biol
2021
34089216
NF-κB Rel subunit exchange on a physiological timescale.
Protein Sci
2021
31769931
ChemBioChem@20-Some Reflections.
Chembiochem
2020
31990523
Targeting Cavity-Creating p53 Cancer Mutations with Small-Molecule Stabilizers: the Y220X Paradigm.
ACS Chem Biol
2020
31633398
A structure-guided molecular chaperone approach for restoring the transcriptional activity of the p53 cancer mutant Y220C.
Future Med Chem
2019
31405179
SLMP53-2 Restores Wild-Type-Like Function to Mutant p53 through Hsp70: Promising Activity in Hepatocellular Carcinoma.
Cancers (Basel)
2019
29069577
Mutant p53 as a therapeutic target for the treatment of triple-negative breast cancer: Preclinical investigation with the anti-p53 drug, PK11007.
Cancer Lett
2018
30068941
Correction: Energy-dependent nucleolar localization of p53 in vitro requires two discrete regions within the p53 carboxyl terminus.
Oncogene
2018
29702446
Aminobenzothiazole derivatives stabilize the thermolabile p53 cancer mutant Y220C and show anticancer activity in p53-Y220C cell lines.
Eur J Med Chem
2018
29382728
The curcumin analog HO-3867 selectively kills cancer cells by converting mutant p53 protein to transcriptionally active wildtype p53.
J Biol Chem
2018
28508083
Structures of closed and open conformations of dimeric human ATM.
Sci Adv
2017
28292898
Multisite aggregation of p53 and implications for drug rescue.
Proc Natl Acad Sci U S A
2017
27551077
2-Sulfonylpyrimidines: Mild alkylating agents with anticancer activity toward p53-compromised cells.
Proc Natl Acad Sci U S A
2016
27821763
Design of a molecular support for cryo-EM structure determination.
Proc Natl Acad Sci U S A
2016
27503952
An in silico algorithm for identifying stabilizing pockets in proteins: test case, the Y220C mutant of the p53 tumor suppressor protein.
Protein Eng Des Sel
2016
27267810
Harnessing Fluorine-Sulfur Contacts and Multipolar Interactions for the Design of p53 Mutant Y220C Rescue Drugs.
ACS Chem Biol
2016
27145840
The p53 Pathway: Origins, Inactivation in Cancer, and Emerging Therapeutic Approaches.
Annu Rev Biochem
2016
25675526
Mechanism of initiation of aggregation of p53 revealed by Φ-value analysis.
Proc Natl Acad Sci U S A
2015
26378745
Experimental and Theoretical Evaluation of the Ethynyl Moiety as a Halogen Bioisostere.
ACS Chem Biol
2015
26636255
Exploiting Transient Protein States for the Design of Small-Molecule Stabilizers of Mutant p53.
Structure
2015
25946337
Deconvoluting Protein (Un)folding Structural Ensembles Using X-Ray Scattering, Nuclear Magnetic Resonance Spectroscopy and Molecular Dynamics Simulation.
PLoS One
2015
25675527
Propagation of aggregated p53: Cross-reaction and coaggregation vs. seeding.
Proc Natl Acad Sci U S A
2015
22777995
Intrinsically disordered p53 and its complexes populate compact conformations in the gas phase.
Angew Chem Int Ed Engl
2013
24277833
Profile of Martin Karplus, Michael Levitt, and Arieh Warshel, 2013 nobel laureates in chemistry.
Proc Natl Acad Sci U S A
2013
24127580
MDMX contains an autoinhibitory sequence element.
Proc Natl Acad Sci U S A
2013
23630318
Small molecule induced reactivation of mutant p53 in cancer cells.
Nucleic Acids Res
2013
23675589
Reply to Campos and Muñoz: Why phosphate is a bad buffer for guanidinium chloride titrations.
Proc Natl Acad Sci U S A
2013
23329326
Don't waste good methods on bad buffers and ambiguous data.
Proc Natl Acad Sci U S A
2013
22176582
Long-range modulation of chain motions within the intrinsically disordered transactivation domain of tumor suppressor p53.
J Am Chem Soc
2012
22972749
Domain-domain interactions in full-length p53 and a specific DNA complex probed by methyl NMR spectroscopy.
Proc Natl Acad Sci U S A
2012
23012405
Sequence-dependent sliding kinetics of p53.
Proc Natl Acad Sci U S A
2012
22955930
In support of the BMRB.
Nat Struct Mol Biol
2012
23035244
Lithocholic acid is an endogenous inhibitor of MDM4 and MDM2.
Proc Natl Acad Sci U S A
2012
23112865
Stability of p53 homologs.
PLoS One
2012
23112193
Chemical physics of protein folding.
Proc Natl Acad Sci U S A
2012
23135266
Evaluating Drosophila p53 as a model system for studying cancer mutations.
J Biol Chem
2012
22869713
Kinetic mechanism of p53 oncogenic mutant aggregation and its inhibition.
Proc Natl Acad Sci U S A
2012
22869710
First-order rate-determining aggregation mechanism of p53 and its implications.
Proc Natl Acad Sci U S A
2012
22439615
Halogen-enriched fragment libraries as leads for drug rescue of mutant p53.
J Am Chem Soc
2012
20650962
Highest paraoxonase turnover rate found in a bacterial phosphotriesterase variant.
Protein Eng Des Sel
2011
21525412
Acetylation of lysine 120 of p53 endows DNA-binding specificity at effective physiological salt concentration.
Proc Natl Acad Sci U S A
2011
21553833
Combination of Markov state models and kinetic networks for the analysis of molecular dynamics simulations of peptide folding.
J Phys Chem B
2011
21639149
Nonnative interactions in the FF domain folding pathway from an atomic resolution structure of a sparsely populated intermediate: an NMR relaxation dispersion study.
J Am Chem Soc
2011
21491862
Electrocatalytic monitoring of metal binding and mutation-induced conformational changes in p53 at picomole level.
J Am Chem Soc
2011
21457718
Interaction of the p53 DNA-binding domain with its n-terminal extension modulates the stability of the p53 tetramer.
J Mol Biol
2011
21422286
Malleability of folding intermediates in the homeodomain superfamily.
Proc Natl Acad Sci U S A
2011
21146541
Time-resolved small-angle X-ray scattering study of the folding dynamics of barnase.
J Mol Biol
2011
21037279
Phosphotriesterase variants with high methylphosphonatase activity and strong negative trade-off against phosphotriesters.
Protein Eng Des Sel
2011
21097469
Single-Molecule characterization of oligomerization kinetics and equilibria of the tumor suppressor p53.
Nucleic Acids Res
2011
21187427
Folding of the Pit1 homeodomain near the speed limit.
Proc Natl Acad Sci U S A
2011
1 - 50 of 551
Column Actions
Search
Recommended Authors
Lewyn Li
Dana-Farber Cancer Institute, Harvard Medical School
Career Start Year
2000
Number of shared co-authors
1
J Michael Sauder
Eli Lilly and Co.
Career Start Year
1996
Number of shared co-authors
3
Shira Albeck
Weizmann Institute of Science
Career Start Year
1996
Number of shared co-authors
6
Andreas Bracher
Max-Planck-Institute of Biochemistry
Career Start Year
1995
Number of shared co-authors
3
Orly Dym
Weizmann Institute of Science
Career Start Year
1995
Number of shared co-authors
6
Volker D??tsch
Institute for Biophysical Chemistry, Goethe-University
Career Start Year
1995
Number of shared co-authors
6
Diana R Tomchick
University of Texas Southwestern Medical Center
Career Start Year
1993
Number of shared co-authors
7
Tobin R Sosnick
Institute for Biophysical Dynamics, The University of Chicago
Career Start Year
1990
Number of shared co-authors
5
P??r Nordlund
Karolinska Institutet, BioClinicum J6
Career Start Year
1989
Number of shared co-authors
3
John F Hunt
Columbia University
Career Start Year
1986
Number of shared co-authors
5
Arun Malhotra
University of Miami Miller School of Medicine
Career Start Year
1986
Number of shared co-authors
2
Raghavan Varadarajan
Indian Institute of Science
Career Start Year
1985
Number of shared co-authors
2
Aled M Edwards
University of Toronto
Career Start Year
1984
Number of shared co-authors
5
Stephen Anderson
Center for Advanced Biotechnology and Medicine, Rutgers University
Career Start Year
1983
Number of shared co-authors
3
Vladimir N Malashkevich
Albert Einstein College of Medicine
Career Start Year
1982
Number of shared co-authors
1
Udo Heinemann
Max-Delbruck-Center for Molecular Medicine in the Helmholtz Association (MDC)
Career Start Year
1980
Number of shared co-authors
4
Ruth Nussinov
Sackler School of Medicine, Tel Aviv University
Career Start Year
1980
Number of shared co-authors
5
Alan R Davidson
University of Toronto, University Avenue
Career Start Year
1980
Number of shared co-authors
8
Michael Brenowitz
Albert Einstein College of Medicine
Career Start Year
1979
Number of shared co-authors
2
Andrzej Joachimiak
Center for Structural Biology of Infectious Diseases, University of Chicago
Career Start Year
1979
Number of shared co-authors
8
Tom Alber
University of California berkeley
Career Start Year
1976
Number of shared co-authors
4
John A Tainer
The University of Texas MD Anderson Cancer Center
Career Start Year
1975
Number of shared co-authors
5
George N Phillips
Rice University
Career Start Year
1974
Number of shared co-authors
6
Charles L Brooks
University of Michigan ann arbor
Career Start Year
1974
Number of shared co-authors
4
Tom L Blundell
Heartand Lung Research Institute, University of Cambridge
Career Start Year
1971
Number of shared co-authors
9
Barry Honig
Columbia University Irving Medical Center
Career Start Year
1971
Number of shared co-authors
4
Sung-Hou Kim
University of California berkeley
Career Start Year
1967
Number of shared co-authors
3
Robert M Stroud
University of California San Francisco
Career Start Year
1965
Number of shared co-authors
4
David Eisenberg
university of california los angeles
Career Start Year
1963
Number of shared co-authors
7
Martin Karplus
Harvard University
Career Start Year
1959
Number of shared co-authors
12
row(s) 1 - 30 of 30
Collaborators
Gideon Schreiber
Co-authored papers
14
Kim Henrick
The State University of New Jersey
Co-authored papers
5
Hartmut Oschkinat
Leibniz-Forschungsinstitut fur Molekulare Pharmakologie
Co-authored papers
5
Carol V Robinson
University of Oxford
Co-authored papers
5
Fernando J Corrales
National Center for Biotechnology
Co-authored papers
5
Lewis E Kay
University of Toronto
Co-authored papers
4
Dmitry M Korzhnev
University of Connecticut Health Center
Co-authored papers
4
Mary M Y Waye
The Chinese University of Hong Kong
Co-authored papers
4
Leonid A Mirny
Co-authored papers
3
Gordon C K Roberts
Leicester Institute of Structural and Chemical Biology, University of Leicester
Co-authored papers
2
Osnat Karni
Columbia University
Co-authored papers
2
Jose Maria Carazo
National Centre for Biotechnology (CNB CSIC), Campus Universidad Autonoma de Madrid
Co-authored papers
2
Mikel Valle
Center for Cooperative Research in Biosciences (CIC bioGUNE)
Co-authored papers
2
Michael J E Sternberg
Imperial College London
Co-authored papers
2
Michele Vendruscolo
University of Cambridge
Co-authored papers
2
Dmitri I Svergun
King's College London BHF Centre for Research Excellence
Co-authored papers
2
Sjors H W Scheres
Medical Research Council Laboratory of Molecular Biology
Co-authored papers
2
Ad Bax
National Institutes of Health
Co-authored papers
2
Andrej Sali (CM4AI)
University of California San Francisco
Co-authored papers
1
Oliver F Lange
Center for Integrated Protein Science, Technische Universitat Munchen
Co-authored papers
1
Josep Rizo
University of Texas Southwestern Medical Center
Co-authored papers
1
Mike P Williamson
The University of Sheffield
Co-authored papers
1
Fred E Cohen
University of California san francisco
Co-authored papers
1
Lu-Yun Lian
Institute of Systems, The University of Liverpool
Co-authored papers
1
Igor L Barsukov
Institute of Integrative Biology, University of Liverpool
Co-authored papers
1
David E Shaw
Columbia University
Co-authored papers
1
Patrick C A van der Wel
Zernike Institute for Advanced Materials, University of Groningen
Co-authored papers
1
David Middleton
Co-authored papers
1
Ioannis Vakonakis
University of Oxford
Co-authored papers
1
Thomas A Frenkiel
The Medical Research Council Biomedical NMR Centre, The Francis Crick Institute
Co-authored papers
1
1 - 30